NCT06499272

Brief Summary

Introduction: New technologies are a support in the rehabilitation of users. The therapeutic approach to cognitive rehabilitation encompasses a variety of techniques, among which traditional occupational therapy stands out. This modality includes a series of interventions such as cognitive stimulation through the use of cards, functional activities, psychomotor exercises, the application of sensory stimuli and the incorporation of music therapy. An additional alternative is to integrate a cognitive stimulation program such as NeuronUP, which is a computerized tool. This integration can increase adherence to treatment and contribute to preserving or improving the individual's cognitive functioning and improving quality of life. Objective: The objective established for this study was to verify whether the combination of occupational therapy with the NeuronUP computer program improves or maintains the cognitive status and quality of life of users with Alzheimer's disease. In addition, to determine whether the use of this program leads to greater adherence to treatment by patients. Material and methods: This is a randomized clinical trial. Participants' cognitive status will be assessed using the MEC (Mini Cognitive Examination) tool, cognitive skills using the LOTCA (Loewenstein Occupational Therapy Cognitive Assessment), and perceived quality of life using the Whoqol-Bref questionnaire. At the end of treatment, the CSQ-8, a tool designed to determine the degree of user satisfaction, will be administered.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable alzheimer-disease

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable alzheimer-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

July 6, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 12, 2024

Completed
Last Updated

July 12, 2024

Status Verified

July 1, 2024

Enrollment Period

7 months

First QC Date

July 6, 2024

Last Update Submit

July 6, 2024

Conditions

Keywords

Alzheimer's DiseaseOccupational TherapyNeuronUPQuality of LifeCognitive StimulationCognitive Impairment

Outcome Measures

Primary Outcomes (3)

  • World Health Organization WHOQOL-BREF

    Self-administered questionnaire, assesses the general perception of quality of life and general perception of health. It is composed of four domains: physical health, psychological health, social relationships and environment. A higher score on this scale indicates a higher quality of life. Potential scores for all domain scores, therefore, range from 4-20

    Pre-intervention and post-intervention (up to 1 week)

  • Mini Cognitive Examination (MEC)

    This test provides information about a person's cognitive state. By means of the score obtained, cognitive impairment can be perceived, being useful for screening purposes. The scores are: No impairment (between 24 and 35 points); probably moderately impaired (between 23 and 18 points); and severely impaired (less than 18 points).

    Pre-intervention and post-intervention (up to 1 week)

  • Loewenstein Occupational Therapy Cognitive Assessment (LOTCA)

    Tool adapted and validated for the Spanish population that assesses cognitive skills in four areas: orientation, visual and spatial perception, visual motor organisation and thinking operations. Scores range from 1 to 4, with the highest score being the best.

    Pre-intervention and post-intervention (up to 1 week)

Secondary Outcomes (1)

  • The Client Satisfaction Questionnaire-8, CSQ-

    Post-intervention (up to 1 week)

Study Arms (2)

Experimental Group (EG)

EXPERIMENTAL

Experimental Group (EG), which received therapy with NeuronUP, plus their conventional occupational therapy sessions.

Procedure: Conventional occupational therapy sessions + NeuronUP

Control Group (CG

ACTIVE COMPARATOR

Control Group (CG), which received their usual sessions of conventional occupational therapy.

Procedure: Conventional occupational therapy sessions

Interventions

Occupational therapy sessions are based on cognitive stimulation, manipulative skill training and psychomotor skills. In addition, 2 sessions per week are conducted with two Nintendo Switch games.

Experimental Group (EG)

Occupational therapy sessions are based on cognitive stimulation, manipulative dexterity training and psychomotor skills.

Control Group (CG

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Adult men or women, aged 65 years or olde.
  • Not present severe cognitive impairment, measured through the Mini Cognitive Examination test (MEC\>22 points).
  • To reside permanently in the Nursing Home.
  • Attend Occupational Therapy sessions regularly.
  • Have adequate manual dexterity to be able to use a Tablet.
  • Agree to participate voluntarily in the study.

You may not qualify if:

  • Having severe cognitive impairment, as measured by the Mini Cognitive Examination (MEC\<22 points).
  • Having comorbid diagnoses such as stroke, brain tumours or heart disease, among others.
  • Not attending Occupational Therapy sessions regularly.
  • Poor adherence to the treatments offered at the centre.
  • Not agreeing to participate voluntarily in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physiocare Madrid Clinic

Madrid, 28026, Spain

Location

MeSH Terms

Conditions

Alzheimer DiseaseCognitive Dysfunction

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersCognition Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: ontrol Group (CG), which received their usual sessions of conventional occupational therapy, and an Experimental Group (EG), which received therapy with NeuronUP, plus their conventional occupational therapy sessions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, Occupational Therapist

Study Record Dates

First Submitted

July 6, 2024

First Posted

July 12, 2024

Study Start

December 1, 2023

Primary Completion

July 1, 2024

Study Completion

July 1, 2024

Last Updated

July 12, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations